menu
    • menu

    Company profile for ImmunogenX

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    Smithfield BioScience transforms bioproducts into trusted, life-saving therapies through safe, reliable U.S.-based manufacturing.

    Virtual Booth

    Contact Supplier

    Quotient Sciences- Molecule to Cure. Fast.

    Virtual Booth

    Contact Supplier

    SWATI - Transforming science into solutions with 60+ years of expertise, global accreditations, and pioneering biotech innovation.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    “ImmunogenX” (a subsidiary of Immunogenics LLC) is a clinical-stage company founded in 2013 and supported by a team of world renowned scientists and collaborators. ImmunogenX was formed to address critical needs for individuals with suspected or diagnosed celiac disease. Our research efforts are focused on therapy, disease management, and food safety. The only current recourse for an individual with celiac disease is a ...
    “ImmunogenX” (a subsidiary of Immunogenics LLC) is a clinical-stage company founded in 2013 and supported by a team of world renowned scientists and collaborators. ImmunogenX was formed to address critical needs for individuals with suspected or diagnosed celiac disease. Our research efforts are focused on therapy, disease management, and food safety. The only current recourse for an individual with celiac disease is a lifelong adherence to a gluten-free diet (GFD). A first area of development is a therapy for the treatment of patients exercising a diligent GFD.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    ImmunogenXUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    1600 Dove Street, Suite 330, Newport Beach
    Telephone
    Telephone
    949-679-0900
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://immunogenx.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Tides Asia

    Tides Asia

    Not Confirmed

    envelop Contact Supplier

    Tides Asia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Entero Cuts Staff, Vacates Office, Pauses R&D Amid Financial Troubles
    Entero Cuts Staff, Vacates Office, Pauses R&D Amid Financial Troubles

    08 Aug 2024

    // FIERCE BIOTECH

    https://www.fiercebiotech.com/biotech/entero-exits-laying-staff-vacating-office-and-pausing-rd-mattress-provides-hard-landing

    FIERCE BIOTECH
    08 Aug 2024
    Share Share
    ImmunogenX and Mayo Clinic Celiac Disease Study Published in Gastroenterology
    ImmunogenX and Mayo Clinic Celiac Disease Study Published in Gastroenterology

    15 Aug 2022

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20220815005130/en

    BUSINESSWIRE
    15 Aug 2022
    Share Share
    ImmunoGen Announces Mature Data from FORWARD II Study Evaluating Mirvetuximab
    ImmunoGen Announces Mature Data from FORWARD II Study Evaluating Mirvetuximab

    18 May 2021

    // IMMUNOGEN

    https://investor.immunogen.com/news-releases/news-release-details/immunogen-announces-mature-data-forward-ii-study-evaluating

    IMMUNOGEN
    18 May 2021
    Share Share
    ImmunogenX and Mayo Clinic Successfully Complete the CeliacShield Trial
    ImmunogenX and Mayo Clinic Successfully Complete the CeliacShield Trial

    18 Mar 2021

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20210318005915/en

    BUSINESSWIRE
    18 Mar 2021
    Share Share
    ImmunogenX and Mayo Clinic Successfully Complete the CeliacShield Trial
    ImmunogenX and Mayo Clinic Successfully Complete the CeliacShield Trial

    18 Mar 2021

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20210318005915/en/ImmunogenX-and-Mayo-Clinic-Successfully-Complete-the-CeliacShield-Trial

    BUSINESSWIRE
    18 Mar 2021
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search